Key Insights

Highlights

Success Rate

90% trial completion (above average)

Published Results

111 trials with published results (18%)

Research Maturity

391 completed trials (64% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

7.2%

44 terminated out of 614 trials

Success Rate

89.9%

+3.3% vs benchmark

Late-Stage Pipeline

16%

99 trials in Phase 3/4

Results Transparency

28%

111 of 391 completed with results

Key Signals

111 with results90% success44 terminated

Data Visualizations

Phase Distribution

494Total
Not Applicable (259)
Early P 1 (5)
P 1 (46)
P 2 (85)
P 3 (40)
P 4 (59)

Trial Status

Completed391
Unknown85
Terminated44
Recruiting41
Withdrawn20
Active Not Recruiting20

Trial Success Rate

89.9%

Benchmark: 86.6%

Based on 391 completed trials

Clinical Trials (614)

Showing 20 of 20 trials
NCT06609343Phase 1Not Yet RecruitingPrimary

Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis

NCT05705414Early Phase 1RecruitingPrimary

Oral Intradialytic Amino Acid Supplementation to Vitalize End-stage Kidney Disease Patients on Hemodialysis

NCT06439862Recruiting

Study of the Quality of Life in School Aged-children With Posterior Urethral Valves

NCT06494631Not ApplicableEnrolling By InvitationPrimary

Xeltis Hemodialysis Access Graft (aXess) US Study

NCT06329310Not ApplicableRecruitingPrimary

Xeltis Hemodialysis Access (aXess) Conduit: aXess-E Study

NCT04163614Not ApplicableRecruitingPrimary

Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients

NCT06326905Not ApplicableRecruiting

CAPABLE Transplant

NCT07710183Not ApplicableRecruitingPrimary

Pumpkin Seed Oil as a Nutraceutical for Hemodialysis Patients

NCT06516653Not ApplicableRecruitingPrimary

Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula

NCT04392206Phase 1RecruitingPrimary

AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses

NCT07696962Phase 1Not Yet RecruitingPrimary

Study of ChoironeX GalKO Porcine Thymokidney Xenotransplantation in End-Stage Renal Disease

NCT06515899CompletedPrimary

Association of Middle Molecules Clearance With HDF Volume

NCT03674307Not ApplicableActive Not Recruiting

Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates

NCT03719339Completed

VIRTUUS Children's Study

NCT07591714Not ApplicableRecruitingPrimary

The Effect of Intradialytic Eye Exercise in Hemodialysis Patients

NCT04817774Phase 1Completed

Safety & Tolerability Study of Chimeric Antigen Receptor T-Reg Cell Therapy in Living Donor Renal Transplant Recipients

NCT06310161Not ApplicableActive Not RecruitingPrimary

Light Therapy in End Stage Kidney Disease

NCT02695641Early Phase 1WithdrawnPrimary

Reduction of Plasma Free VEGF-A Using Low-dose Bevacizumab in Hemodialysis Patients

NCT07663279Not ApplicableNot Yet RecruitingPrimary

BicMag Study - Improving Mineral Buffering Capacity in Dialysis Patients

NCT07020832Phase 3Suspended

Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High Risk of Delayed Graft Function (DGF) Following Kidney Allograft Transplantation

Scroll to load more

Research Network

Activity Timeline